Elevation of Sema4A Implicates Th Cell Skewing and the Efficacy of IFN-{beta} Therapy in Multiple Sclerosis
The Journal of Immunology, 05/07/2012
Nakatsuji Y et al. – The results suggest that Sema4A is involved in the pathogenesis of Multiple sclerosis (MS) by promoting Th17 skewing.



